Analysts: Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

9.05USD
4:00pm EDT
Price Change (% chg)

$-0.05 (-0.55%)
Prev Close
$9.10
Open
$9.20
Day's High
$9.28
Day's Low
$8.79
Volume
535,338
Avg. Vol
553,951
52-wk High
$9.98
52-wk Low
$1.68

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 December 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 6 6 5 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.56 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 9 2.22 20.00 0.00 0.00
Quarter Ending Dec-13 9 0.00 0.00 0.00 2.77
Year Ending Dec-13 9 9.22 27.00 7.00 9.48
Year Ending Dec-14 8 49.89 92.35 4.10 46.19
Earnings (per share)
Quarter Ending Sep-13 9 -0.08 0.15 -0.13 -0.08
Quarter Ending Dec-13 9 -0.11 -0.10 -0.14 -0.06
Year Ending Dec-13 9 -0.33 -0.07 -0.40 -0.26
Year Ending Dec-14 8 0.00 0.84 -0.40 0.19

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-13 0.00 0.00 0.00 0.00
Quarter Ending Mar-13 5.83 7.00 1.17 20.00
Quarter Ending Dec-12 0.00 0.00 0.00 0.00
Quarter Ending Sep-12 0.00 0.00 0.00 0.00
Quarter Ending Jun-12 0.30 0.00 0.30 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 2.22 2.22 2.22 2.50 0.00
Quarter Ending Dec-13 0.00 0.00 0.00 0.00 2.77
Year Ending Dec-13 9.22 9.22 9.22 9.50 9.48
Year Ending Dec-14 49.89 48.79 48.79 51.84 46.19

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks